Literature DB >> 7378258

Effect of quinidine on plasma concentration and renal clearance of digoxin. A clinically important drug interaction.

R Dahlqvist, G Ejvinsson, K Schenck-Gustafsson.   

Abstract

1 Thirty patients on maintenance digoxin therapy and admitted for cardioversion of atrial fibrillation were closely monitored with regard to plasma levels of digoxin and quinidine. 2 Seventeen of these patients were kept on maintenance digoxin therapy. After an initial lag period of 6 to 18 h after the addition of quinidine their digoxin levels started to increase and had increased by between 20 and 330% after 3 days on quinidine. Side-effects attributed to the raised digoxin concentration occurred in 6 of these patients. 3 As studied in 5 of these 17 patients the renal clearance of digoxin decreased markedly when quinidine was added to the therapy. There was also a slight but significant reduction in creatinine clearance (n = 4). 4 In 13 patients digoxin was discontinued 36 h prior to the first quinidine dose. Also in these patients digoxin plasma levels increased significantly. 5 It is concluded that quinidine causes an unpredictably large increase in plasma digoxin and that this effect is probably at least initially to a large part due to a redistribution of digoxin in the body. The relative contributions of re-distribution and impaired renal clearance of digoxin to the increase in digoxin steady-state levels are presently unknown. 6 It is recommended that close monitoring of digoxin concentration and appropriate reduction of the maintenance dose is undertaken when quinidine is to be given to patients on digitalis therapy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7378258      PMCID: PMC1429984          DOI: 10.1111/j.1365-2125.1980.tb01070.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  18 in total

1.  Estimation of population characteristics of pharmacokinetic parameters from routine clinical data.

Authors:  L B Sheiner; B Rosenberg; V V Marathe
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

2.  Pharmacokinetics of digoxin: comparison of a two- and a three-compartment model in man.

Authors:  W G Kramer; R P Lewis; T C Cobb; W F Forester; J A Visconti; L A Wanke; H G Boxenbaum; R H Reuning
Journal:  J Pharmacokinet Biopharm       Date:  1974-08

3.  [Serum creatinine determination without protein precipitation].

Authors:  H Bartels; M Böhmer; C Heierli
Journal:  Clin Chim Acta       Date:  1972-03       Impact factor: 3.786

4.  Direct-current shock in the treatment of cardiac arrhythmias. A clinical study.

Authors:  H Derweduwen; J Enderle; H De Geest; O Polis; J C Vancrombreucq; J V Joossens
Journal:  Acta Cardiol       Date:  1969       Impact factor: 1.718

5.  An improved method of digoxin therapy.

Authors:  R W Jelliffe
Journal:  Ann Intern Med       Date:  1968-10       Impact factor: 25.391

6.  Countershock exposed quinidine syncope.

Authors:  A Castellanos; L Lemberg; D Johnson; H Gilmore
Journal:  Am J Med Sci       Date:  1965-09       Impact factor: 2.378

7.  Effect of quinidine on plasma concentrations of digoxin.

Authors:  G Ejvinsson
Journal:  Br Med J       Date:  1978-02-04

8.  [Quinidine-induced paroxysmal ventricular fibrillation].

Authors:  C Bjerkelund; K Skåland
Journal:  Nord Med       Date:  1967-01-19

9.  Interaction between quinidine and digoxin.

Authors:  E B Leahey; J A Reiffel; R E Drusin; R H Heissenbuttel; W P Lovejoy; J T Bigger
Journal:  JAMA       Date:  1978-08-11       Impact factor: 56.272

10.  Spironolactone-induced changes in digoxin kinetics.

Authors:  S Waldorff; J D Andersen; N Heebøll-Nielsen; O G Nielsen; E Moltke; U Sørensen; E Steiness
Journal:  Clin Pharmacol Ther       Date:  1978-08       Impact factor: 6.875

View more
  15 in total

1.  Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein.

Authors:  Jun-Sheng Wang; Hao-Jie Zhu; John S Markowitz; Jennifer L Donovan; C Lindsay DeVane
Journal:  Psychopharmacology (Berl)       Date:  2006-06-30       Impact factor: 4.530

Review 2.  Drug transporters in pharmacokinetics.

Authors:  Ernst Petzinger; Joachim Geyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-03-11       Impact factor: 3.000

Review 3.  Pharmacokinetic interactions with digoxin.

Authors:  S M Rodin; B F Johnson
Journal:  Clin Pharmacokinet       Date:  1988-10       Impact factor: 6.447

Review 4.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

Review 5.  The quinidine-digoxin interaction in perspective.

Authors:  B Fichtl; W Doering
Journal:  Clin Pharmacokinet       Date:  1983 Mar-Apr       Impact factor: 6.447

6.  On the interaction between phenytoin and digoxin.

Authors:  H Rameis
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  Pharmacokinetic concepts - drug binding, apparent volume of distribution and clearance.

Authors:  M Gibaldi; J R Koup
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

8.  No effect of probenecid on the renal and biliary clearances of digoxin in man.

Authors:  A Hedman; B Angelin; A Arvidsson; R Dahlqvist
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

9.  Quinidine-digoxin interaction: evidence for involvement of an extrarenal mechanism.

Authors:  W Doering; B Fichtl; M Herrmann; E Besenfelder
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

10.  A Pharmacokinetic and Pharmacodynamic Study of Intravenous Levosimendan in Healthy Chinese Volunteers and Ethnic Comparisons.

Authors:  Kai-Min Chu; Yoa-Pu Hu; Jun-Ting Liou
Journal:  Acta Cardiol Sin       Date:  2014-07       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.